At the 8-week treatment , the mean weight and the total cholesterol , triglyceride , and low-density lipoprotein cholesterol levels increased significantly in the olanzapine group ( p = 0.037 , p = 0.029 , p = 0.030 , and p = 0.028 , respectively ) .